• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    NodThera`s NLRP3 inhibitor shows obesity promise in early trial

    FIERCE BIOTECH

    NodThera touts potential weight loss effect of NLRP3 inhibitors

    ENDPTS

    NodThera Announces Positive Phase 1 Study Readouts for the NLRP3

    PRNEWSWIRE

    NodThera Announces Progress of NT-0796, a Novel NLRP3 Inflammasome

    PRNEWSWIRE

    Roche doubles down on promising inflammation field with Inflazome buy

    SEEKING ALPHA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.